Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
Behavioral sciences approach to risk management
Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.
SEC priorities for asset management industry
David Tittsworth, Ropes & Gray investment management counsel, examines what’s changed for the asset management industry under the Trump administration and what to expect during 2018.
Anti-corruption & international risk developments
Alex Rene, co-chair of Ropes & Gray’s anti-corruption / international risk practice and managing partner of the firm’s Washington, D.C. office, discusses recent FCPA enforcement activity as well as international risks facing companies.
International trade developments
Ama Adams, Ropes & Gray litigation & enforcement partner, discusses the complex array of trade laws and regulations facing companies with international operations.
Enforcement of electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, addresses an emerging trend in the electronic health records space, where a number of companies are being investigated under the False Claims Act.
Impact of changes at the PTAB on patent owners
Scott McKeown, Ropes & Gray IP litigation partner and chair of the firm’s Patent Trial and Appeal Board (PTAB) group, examines how some recent changes at the PTAB will benefit patent owners.